Neratinib Options
For illustration, it has been shown that prime-dose CsA—but not very low dose CsA—specifically inhibits the expression of NFATc1 and IL-two in human T cells from stimulated complete blood samples, assessed by flow cytometry (23). Thus, unlike other cytotoxic immune suppressors, CsA won't kill the immune effector cells but alternatively selectiv